![Gregory Gorgas](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gregory Gorgas
Vorstandsvorsitzender bei
ARTELO BIOSCIENCES, INC.
Vermögen: 1 590 $ am 31.05.2026
Profil
Gregory D.
Gorgas was the founder of Theragence, Inc., founded in 2009, where the title held was Managing Director from 2009 to 2011.
Current jobs include President, CEO, Secretary & Director at Artelo Biosciences, Inc. starting in 2025; Director at Klotho Therapeutics, Inc.; and Director at Theragence, Inc. Former jobs include Senior Director-Global & United States Marketing at Biogen, Inc. from 2006 to 2008; Senior Vice President-Commercial & Corporate at Mast Therapeutics, Inc. from 2011 to 2017; and Senior Vice President-Commercial at Savara, Inc. Education includes undergraduate studies at The California State University and an MBA from the University of Phoenix.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 20.02.2026 | 1’136 ( 0.05% ) | 1 590 $ | 31.05.2026 |
Aktive Positionen von Gregory Gorgas
| Unternehmen | Position | Beginn |
|---|---|---|
| ARTELO BIOSCIENCES, INC. | Vorstandsvorsitzender | 03.04.2017 |
Klotho Therapeutics, Inc.
 Klotho Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops patent-pending Klotho protein for diseases of aging, cancer, and kidney disease | Direktor/Vorstandsmitglied | - |
Theragence, Inc.
 Theragence, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical preparations | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Gregory Gorgas
| Unternehmen | Position | Ende |
|---|---|---|
Mast Therapeutics, Inc.
 Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapies for serious or life-threatening diseases with significant unmet needs | Corporate Officer/Principal | 01.01.2017 |
| SAVARA INC. | Corporate Officer/Principal | 28.12.2016 |
Theragence, Inc.
Theragence, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical preparations | Vorstandsvorsitzender | 01.07.2011 |
| BIOGEN INC. | Vertrieb & Marketing | 01.10.2008 |
Ausbildung von Gregory Gorgas
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
71
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapies for serious or life-threatening diseases with significant unmet needs | Health Technology |
Artelo Biosciences, Inc.
 Artelo Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops endocannabinoid system modulating therapeutics | Health Technology |
The California State University
 The California State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Phoenix
 University of Phoenix Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Theragence, Inc.
Theragence, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical preparations | Health Technology |
Savara, Inc.
 Savara, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals to treat respiratory diseases | Health Technology |
Klotho Therapeutics, Inc.
Klotho Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops patent-pending Klotho protein for diseases of aging, cancer, and kidney disease | Commercial Services |
